Nicotine Transdermal System Patch Patch, Extended Release
Product Images NDC 68001-699

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Nicotine Transdermal System Patch (NDC 68001-699). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bluepoint Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

14mg 7 Patches (Nicotine Transdermal System Patch 14mg 7 Patches)

14mg 7 Patches (Nicotine Transdermal System Patch 14mg  7 Patches)
Nicotine Transdermal System Patch Step 2 14 mg/24 hours extended release patch packaging label by BluePoint Laboratories. The carton highlights the product strength, usage as a stop smoking aid, a 7-patch supply (1 week kit), and includes behavioral support with a self-help guide. The label features active ingredient and usage instructions, warnings, and manufacturer information.*
FDA Label Image

14mg 14 Patches (Nicotine Transdermal System Patch 14mg 14 Patches)

14mg 14 Patches (Nicotine Transdermal System Patch 14mg 14 Patches)
Nicotine Transdermal System Patch Step 2, 14 mg/24hr extended-release transdermal patch for smoking cessation, labeled as a STOP SMOKING AID. Manufactured by BluePoint Laboratories, this package contains 14 patches (a 2-week kit). The label includes directions, warnings, inactive ingredients, and instructions for use based on cigarette consumption.*
FDA Label Image

21 mg 14 Patches (Nicotine Transdermal System Patch 21mg 14patches)

21 mg 14 Patches (Nicotine Transdermal System Patch 21mg 14patches)
Packaging label for Nicotine Transdermal System Patch Step 1, 21 mg delivered over 24 hours, an extended-release transdermal patch for smoking cessation. The label shows a 14-patch package (2 week kit) from BluePoint Laboratories and includes directions, warnings, ingredients, and a barcode. It highlights the product strength and usage instructions as a stop smoking aid.*
FDA Label Image

21mg 28 Patches (Nicotine Transdermal System Patch 21mg 28patches)

21mg 28 Patches (Nicotine Transdermal System Patch 21mg 28patches)
Nicotine Transdermal System Patch Step 2, 21 mg/24h extended-release transdermal patch for smoking cessation by BluePoint Laboratories. The label specifies 28 patches (4 week kit) with instructions and warnings on usage, inactive ingredients, and support program details. The product is labeled as a stop smoking aid.*
FDA Label Image

21mg 7 Patches (Nicotine Transdermal System Patch 21mg 7 Patches)

21mg 7 Patches (Nicotine Transdermal System Patch 21mg 7 Patches)
Packaging label for Nicotine Transdermal System Patch Step 1 by BluePoint Laboratories. The patch delivers 21 mg of nicotine over 24 hours as a stop smoking aid. The box contains 7 patches, designed as a 1-week kit with a behavior support program and self-help guide included. The label includes drug facts, directions for use, warnings, and inactive ingredients.*
FDA Label Image

7mg 14 Patches (Nicotine Transdermal System Patch 7mg 14 Patches)

7mg 14 Patches (Nicotine Transdermal System Patch 7mg 14 Patches)
Packaging label for Nicotine Transdermal System Patch Step 2, delivering 7 mg of nicotine over 24 hours. The extended-release patch is a stop smoking aid provided by BluePoint Laboratories. The carton contains 14 patches, a 2-week kit, and includes a behavior support program with a self-help guide. The label includes directions, warnings, and inactive ingredients.*
FDA Label Image

7mg (Nicotine Transdermal System Patch 7mg 7 Patches)

7mg (Nicotine Transdermal System Patch 7mg 7 Patches)
Nicotine Transdermal System Patch Step 3, 7 mg/24h extended-release transdermal patch, labeled as a stop smoking aid. The package contains 7 patches (1 week kit) and is manufactured by BluePoint Laboratories. The label also includes usage directions, warnings, and information about a behavior support program with a self-help guide.*
FDA Label Image

Steps (Steps)

Steps (Steps)
An illustrated dosing schedule for Nicotine Transdermal System Patch indicating usage over eight weeks. Weeks 1 through 4 feature Step 1 with use of one 21 mg/24h patch daily in red background. Weeks 5 and 6 show Step 2 with one 14 mg/24h patch daily in yellow background. Weeks 7 and 8 depict Step 3 with one 7 mg/24h patch daily in blue background.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.